-
1
-
-
65549107728
-
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: Retrospective analysis of a multicenter phase III study
-
Carnevale-Schianca F, Leisenring W, Martin PJ, Furlong T, Schoch G, Anasetti C et al. Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study. Biol Blood Marrow Transplant 2009; 15: 749-756.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 749-756
-
-
Carnevale-Schianca, F.1
Leisenring, W.2
Martin, P.J.3
Furlong, T.4
Schoch, G.5
Anasetti, C.6
-
2
-
-
44449103854
-
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: A comparison of myeloablative and nonmyeloablative conditioning regimens
-
DOI 10.1038/sj.bmt.1705987, PII 1705987
-
Sala-Torra O, Martin PJ, Storer B, Traina F, Sorror ML, Storb R et al. Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison ofmyeloablative and nonmyeloablative conditioning regimens. Bone Marrow Transplant 2008; 41: 887-893. (Pubitemid 351761691)
-
(2008)
Bone Marrow Transplantation
, vol.41
, Issue.10
, pp. 887-893
-
-
Sala-Torra, O.1
Martin, P.J.2
Storer, B.3
Traina, F.4
Sorror, M.L.5
Storb, R.6
Sandmaier, B.M.7
Flowers, M.E.D.8
-
3
-
-
21044442225
-
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept
-
DOI 10.1038/sj.bmt.1704929
-
Wolff D, Roessler V, Steiner B, Wilhelm S, Weirich V, Brenmoehl J et al. Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplant 2005; 35: 1003-1010. (Pubitemid 40711838)
-
(2005)
Bone Marrow Transplantation
, vol.35
, Issue.10
, pp. 1003-1010
-
-
Wolff, D.1
Roessler, V.2
Steiner, B.3
Wilhelm, S.4
Weirich, V.5
Brenmoehl, J.6
Leithaeuser, M.7
Hofmeister, N.8
Junghanss, C.9
Casper, J.10
Hartung, G.11
Holler, E.12
Freund, M.13
-
4
-
-
67651230892
-
Improved survival and preserved antiviral responses after combination therapy with daclizumab and infliximab in steroid-refractory graft-versus-host disease
-
Rao K, Rao A, Karlsson H, Jagani M, Veys P, Amrolia PJ. Improved survival and preserved antiviral responses after combination therapy with daclizumab and infliximab in steroid-refractory graft-versus-host disease. J Pediatr Hematol Oncol 2009; 31: 456-461.
-
(2009)
J Pediatr Hematol Oncol
, vol.31
, pp. 456-461
-
-
Rao, K.1
Rao, A.2
Karlsson, H.3
Jagani, M.4
Veys, P.5
Amrolia, P.J.6
-
5
-
-
75049084631
-
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
-
Furlong T, Martin P, Flowers ME, Carnevale-Schianca F, Yatscoff R, Chauncey T et al. Therapy with mycophenolate mofetil for refractory acute and chronic GVHD. Bone Marrow Transplant 2009; 44: 739-748.
-
(2009)
Bone Marrow Transplant
, vol.44
, pp. 739-748
-
-
Furlong, T.1
Martin, P.2
Flowers, M.E.3
Carnevale-Schianca, F.4
Yatscoff, R.5
Chauncey, T.6
-
6
-
-
78149464995
-
Prognostic factors and outcomes of severe gastrointestinal graft versus host disease (GI GVHD) after allogeneic hematopoietic stem cell transplantation
-
abstract 336
-
Castilla-LLorente C, Nash RA, McDonald GB, Storer BE, Martin PJ. Prognostic factors and outcomes of severe gastrointestinal graft versus host disease (GI GVHD) after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15(Suppl 2); S120 (abstract 336).
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, Issue.SUPPL. 2
-
-
Castilla-Llorente, C.1
Nash, R.A.2
McDonald, G.B.3
Storer, B.E.4
Martin, P.J.5
-
7
-
-
49349086756
-
Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor
-
Taniguchi Y, Yoshihara S, Hoshida Y, Inoue T, Fujioka T, Ikegame K et al. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. Exp Hematol 2008; 36: 1216-1225.
-
(2008)
Exp Hematol
, vol.36
, pp. 1216-1225
-
-
Taniguchi, Y.1
Yoshihara, S.2
Hoshida, Y.3
Inoue, T.4
Fujioka, T.5
Ikegame, K.6
-
8
-
-
0141702025
-
Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor
-
DOI 10.1038/sj.bmt.1704170
-
Wiesmann A, Bader P, Bamberg M, Faul C, Kanz L, Einsele H. Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor. Bone Marrow Transplant 2003; 32: 511-513. (Pubitemid 37160967)
-
(2003)
Bone Marrow Transplantation
, vol.32
, Issue.5
, pp. 511-513
-
-
Wiesmann, A.1
Bader, P.2
Bamberg, M.3
Faul, C.4
Kanz, L.5
Einsele, H.6
-
9
-
-
13944262008
-
Second allografts for relapsed hematologic malignancies: Feasibility of using a different donor
-
DOI 10.1038/sj.bmt.1704761
-
Duus JE, Stiff PJ, Choi J, Parthasarathy M, Rodriguez T, Toor AA. Second allografts for relapsed hematologic malig-nancies: feasibility of using a different donor. Bone Marrow Transplant 2005; 35: 261-264. (Pubitemid 40268297)
-
(2005)
Bone Marrow Transplantation
, vol.35
, Issue.3
, pp. 261-264
-
-
Duus, J.E.1
Stiff, P.J.2
Choi, J.3
Parthasarathy, M.4
Rodriguez, T.5
Toor, A.A.6
-
10
-
-
38349049150
-
Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection
-
Byrne BJ, Horwitz M, Long GD, Gasparetto C, Sullivan KM, Chute J et al. Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection. Bone Marrow Transplant 2008; 41: 39-43.
-
(2008)
Bone Marrow Transplant
, vol.41
, pp. 39-43
-
-
Byrne, B.J.1
Horwitz, M.2
Long, G.D.3
Gasparetto, C.4
Sullivan, K.M.5
Chute, J.6
|